Alerts will be sent to your verified email
Verify Email
CAMLIN-RE
|
CAMLIN-RE
|
JG Chemicals
|
Eiko Lifesciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
n/a | 19.16 % | -16.62 % |
|
5yr average Equity Multiplier
|
n/a | 1.46 | 2.12 |
|
5yr Average Asset Turnover Ratio
|
n/a | 2.04 | 0.56 |
|
5yr Avg Net Profit Margin
|
n/a | 6.22 % | -3.7 % |
|
Price to Book
|
0.0 | 4.27 | 1.3 |
|
P/E
|
0.0 | 30.73 | 27.97 |
|
5yr Avg Cash Conversion Cycle
|
n/a | 84.89 Days | 61.48 Days |
|
Inventory Days
|
n/a | 40.9 Days | 214.38 Days |
|
Days Receivable
|
n/a | 55.64 Days | 57.98 Days |
|
Days Payable
|
n/a | 5.23 Days | 248.22 Days |
|
5yr Average Interest Coverage Ratio
|
n/a | 23.71 | -0.09 |
|
5yr Avg ROCE
|
n/a | 29.01 % | -109.51 % |
|
5yr Avg Operating Profit Margin
|
n/a | 8.98 % | -9.68 % |
|
5 yr average Debt to Equity
|
n/a | 0.34 | 0.3 |
|
5yr CAGR Net Profit
|
n/a | 22.26 % | 60.2 % |
|
5yr Average Return on Assets
|
n/a | 12.9 % | -4.56 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
n/a | 70.99 % | 36.74 % |
|
Share Pledged by Promoters
|
n/a | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
n/a | 0.0 | 23.26 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 | 0.0 |
|
CAMLIN-RE
|
JG Chemicals
|
Eiko Lifesciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|